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Abstract
Background: The leucine metabolite β-hydroxy-β-methylbutyrate (HMB) is widely used as an ergogenic
supplement to increase resistance-training induced gains in fat free mass (FFM) and strength in healthy adults.
Recent studies have questioned the effectiveness of HMB, particularly when a high protein diet is habitually
consumed. To investigate the additive resistance-training induced effects of HMB and protein in untrained
individuals, we conducted a randomized double-blind, placebo-controlled study that compared the effects of
combined protein and HMB supplementation to protein supplementation alone on FFM and muscle strength after
12-week resistance training.
Methods: Sixteen healthy men (22 ± 2 yrs) performed a periodized resistance-training program for twelve weeks
(four sessions per week). The program comprised two mesocycles, characterized by a linear periodization and non-
linear periodization, respectively, and separated by a 1-week tapering period. All participants received 60 g of whey
protein on training days and 30 g of whey protein (WP) on non-training days. Participants were randomly assigned
to additionally receive 3 g of calcium HMB (WP + HMB) or a placebo (WP + PLA). Body composition and physical
fitness were tested before and after the 12-week training program. Whole-body and arm and leg fat free mass
(FFM) were assessed by bioimpedance spectroscopy; upper arm and leg fat free cross sectional areas were
also quantified using magnetic resonance imaging (MRI); upper and lower body strength were measured by One-
repetition maximum (1-RM) bench press and leg press.
Results: Whole-body and segmental FFM increased in both groups (P < 0.001). However, gains in leg FFM were
higher in WP + HMB vs. WP + PLA (arm FFM: + 6.1% vs. + 9.2%, P = 0.2; leg FFM: + 14.2% vs. + 7.0%, P < 0.01). No
change in fat mass was observed (P = 0.59). 1-RM increased in both groups (P < 0.001).
Conclusions: Combined protein and HMB supplementation resulted in segmental, but not whole-body increases in
FFM compared to protein supplementation alone. These findings could explain some of the controversial effects of
HMB reported in previous studies and have practical implications for maximizing training-induced gains in FFM and
clinical conditions associated with skeletal muscle deconditioning such as aging, sedentary lifestyles, bed rest and
spaceflight.
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Introduction
β-hydroxy-β-methylbutyrate (HMB) is a metabolite of
the branched-chain amino acid leucine, which has
received increasing interest as an ergogenic aid for
training-induced gains in strength and body compos-
ition. The mechanisms behind HMB supplementation
are related to both anti-catabolic and anabolic effects,
enhancing protein synthesis via a mammalian target of
rapamycin (mTOR) dependent mechanism, and inhibit-
ing the ubiquitin-proteasome proteolytic pathway re-
sponsible for the specific degradation of intracellular
proteins [1]. There is also evidence that HMB regulates
adipose tissue function including fatty acid oxidation,
lipolysis, and adipokine secretion, which may be medi-
ated by mTOR and p-AMP-activated protein kinase α
(AMPKα) [2]. Combined HMB-supplementation and
resistance training has been reported to positively affect
health and physical performance by increasing the fat
free mass (FFM) and decreasing fat mass (FM), reducing
muscle soreness and improving strength in both previ-
ously untrained and trained individuals [3–8]. Increased
FFM has also been shown to increase metabolic rate [9],
maximal oxygen uptake, and ventilatory thresholds [10,
11]. These adaptations have been attributed to the
AMPKα-mTOR pathway and its effect on mitochondrial
biogenesis, oxygen consumption and the efficiency of
carbohydrate, glycogen and fat metabolism [12]. How-
ever, various studies have also questioned the effective-
ness of HMB to augment lean mass and performance
gains with resistance training in healthy adults [13–17].
Systematic reviews show that about one-third of the
studies could not confirm any benefits on strength
training-induced effects of HMB on body composition
[1, 18, 19]. Some of the conflicting results might be
attributed to study designs and methodological issues. In
particular, it should be noted that the majority of previ-
ous strength training studies on HMB were rather short,
lasting eight weeks or less. There is also increasing
interest whether HMB supplementation can augment
strength training-induced gains in FFM when a high-
protein diet is provided [5, 20–23]. Recent studies
suggest that protein balance is the critical driver for
strength-training induced changes in muscle mass in
resistance-trained men [20, 22, 23]. Accordingly, it has
been questioned whether HMB supplementation can
provide any additional benefits over and above regular
protein intake on body composition and performance.
To investigate whether a combination of whey protein
and calcium HMB exert additive effects on FFM and
strength in untrained individuals, we conducted a
randomized controlled trial in which healthy young men
received a protein supplementation and HMB or protein
supplementation and placebo during a periodized
12-week resistance training program.
Methods
Experimental design
A randomized, double-blinded, placebo-controlled de-
sign was conducted to investigate the effects of a
12-week strength training program and protein supple-
mentation with and without HMB. The study was ap-
proved by the Ethics Committee for Human Research at
Stellenbosch University and conformed to all standards
of human research set out in the declaration of Helsinki.
All participants were informed about the purpose,
experimental procedures, and risks before giving their
verbal and written informed consent.
Experimental procedures
All participants were provided with a protein and carbo-
hydrate supplement. In addition, the treatment group
was supplemented with HMB, whereas the control
group was treated with an identically looking placebo
(see details below). Group allocation was performed
using a stratified randomization procedure to account
for the effects of body mass. The total sample was paired
based on body mass (i.e., eight pairs), and each partici-
pant within each a pair was randomly assigned to either
the placebo or the HMB group. After one week of
familiarization with the training and testing procedures,
all participants performed a full-body strength training
program for twelve weeks. Missing more than three
training sessions or failure to comply with the supple-
mentation resulted in exclusion from the study. Body
composition and physical fitness were tested before and
after completion of the strength training program, using
the following outcomes. Magnetic resonance imaging
(MRI) was performed to determine changes in upper
arm and upper leg fat free cross-sectional area (CSAFFM).
Upper and lower limb, as well whole-body FFM were
determined by bioimpedance spectroscopy (BIS). One-
repetition maximum (1-RM) bench press and leg press
were used to test upper and lower body strength, re-
spectively. Finally, aerobic capacity was assessed by max-
imal oxygen uptake (V˙O2max). A detailed timeline of
testing and training is depicted in Fig. 1. All testing was
performed between 9.00 a.m. and 2.00 p.m., while pre
and post measurements were performed at approxi-
mately the same time for each individual. To ensure nor-
mohydration, participants were advised to drink at least
2 to 3 L of water per day during the week preceding the
assessments and instructed to refrain from drinking cof-
fee on the days of testing.
Subjects
Participants were healthy men between 19 and 25 years old,
nonsmokers, free of any cardiovascular or metabolic dis-
eases, and orthopedic problems that would limit completion
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of the study. They had not performed any resistance train-
ing exercises or taken any nutritional supplements within
the previous six months, were currently not taking medica-
tion, ergogenic aids, non-prescription drugs, or any other
supplements other than those prescribed by the nutritional
protocol during the study. They agreed to abstain from any
physical exercise other than that prescribed by the program
and agreed to maintain their regular diet throughout the
study. Following an interview and a screening of their med-
ical history, a total of 16 healthy men were included in the
study. One subject discontinued the intervention because of
an accident unrelated to the study. Based on previous stud-
ies this sample size was considered sufficient to detect an ef-
fect of HMB on FFM [4, 8]. Participants were matched for
age, body mass, height, vertical jump height, and strength,
and then randomly split into a treatment group who was
supplemented with whey protein and HMB (WP+HMB),
and a control group who received the same amount of pro-
tein and a placebo (WP+ PLA).
Supplementation
Participants consumed 30 g of whey protein powder
(EVOX® Advanced Nutrition, Synergy Whey Protein, Jo-
hannesburg, South Africa) dissolved in 200–300 ml of
tap water immediately before exercise and about one
hour after completion of exercise on training days, as
well as 30 g of carbohydrate powder (EVOX® Advanced
Nutrition, Super Carbo, Johannesburg, South Africa) dis-
solved in 200–300 ml of tap water immediately after ter-
mination of exercise. On non-training days, subjects
ingested one serving (30 g) of the whey protein supple-
ment in the mornings only. The additional total energy
intake was 1363 kJ (protein: 884 kJ; carbohydrates: 479
kJ) on training days, and 422 kJ on non-training (protein
only) days. Details of the supplements are given in the
Additional file 1: Table S1. The total amount of essential
amino acids, branched-chain amino acids and leucine
were about 20.6 g, 9.7 g and 4.4 g for the 60 g servings,
and 10.3 g, 4.85 g and 2.2 g for the 30 g servings, respect-
ively. In addition to carbohydrate and protein supple-
mentation, WP +HMB ingested a total of 3 g of HMB
daily in the form of capsules, each containing 0.5 g of
calcium HMB (EVOX® Advanced Nutrition, HMB,
Johannesburg, South Africa). Two capsules were taken
three times daily in the mornings, at lunch, and in the
evenings. WP + PLA received identical-looking placebo
capsules, containing microcrystalline cellulose. The cap-
sules were packed in small sachets, one for each day,
each indicating the coded identity of the subject as well
as the day of supplementation. The protein and carbohy-
drate supplementation were supplied in small plastic sa-
chets labeled with each study day. Supplements for
one week were handed out at the beginning of each
week. Compliance with supplementation was ensured by
controlling the empty sachets, assessment of supplement
logs by the end of each week, written as well as verbal
reminders at each workout session by the training in-
structors, and personal interviews with each subject re-
garding the individual progress and program compliance
every second week. Dietary habits were not assessed but
expected not to change throughout the study as all par-
ticipants resided on campus and consumed most of their
meals from the campus cafeteria.
Strength exercise training protocol
The strength training protocol consisted of a 12-week,
four sessions per week, upper/lower body split routine.
Lower body training was performed on Mondays and
Thursdays, whereas upper body training was conducted
on Tuesdays and Fridays. Subjects rested on Wednes-
days and weekends. These days could also be used to
make up missed sessions without jeopardizing a mini-
mum of 48 h of rest between two consecutive upper or
lower body workouts. The training protocol comprised
two mesocycles (weeks 1 to 6 and weeks 8 to 12), which
were separated by a 1-week taper phase. During the first
mesocycle, training was periodized in a linear, i.e., classical
manner by gradually increasing intensity and decreasing
volume. The second mesocycle was characterized by a
nonlinear, i.e., undulated, periodization by coupling lower
(12-RM) with higher (8-RM) intensity workout sessions.
In addition, the exercises were slightly varied between two
consecutive training days (dumbbell vs. barbell or inclined
vs. flat) to ensure varying muscle stress between exercise
sessions. A detailed outline of the training protocol is
provided in the Additional file 2: Table S2. Exercise
intensity was regulated by RM. If the prescribed amount
of repetitions could be completed, the weight was
BIS 1-RMMRIMRI BIS
24 h 24 h 24 h 48 h 24 h 48 h 24 h 24 h 24 h
1-RM1-week Familiarization 12-week TrainingVO2max VO2max
Fig. 1 Detailed timeline of training and testing. All tests were separated by 24 h. Tests immediately following completion of familiarization as well
as training were performed after a 72 h-resting period to minimize effects related to delayed onset muscle soreness (DOMS) and
post-exertion swelling
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increased. All training sessions were performed under the
supervision of certified strength training instructors. Each
training session was documented in a training log and
inspected at the end of each week.
Strength testing
Employing free-weight bench press and a 45-degree ma-
chine leg press, upper and lower body strength were
assessed according to standard guidelines [24]. Initially,
participants warmed up on a stationary ergometer at low
intensity (1W·kg− 1) for 5min and performed static stretch-
ing exercises for an additional 5min. Subsequently, a light
resistance was chosen that easily allowed 5 to 10 repetitions
(approximately 50 to 60% of 1-RM). After a brief rest
period, this resistance was increased by 5 to 10% for bench
press, and 10 to 20% for leg press, and subjects were asked
to complete 3 to 5 repetitions. Following a 2-min rest, a
conservative, near-maximum load was estimated that
allowed subjects to complete 2 to 3 repetitions by further
increasing the weight by 5 to 10% for bench press, and
10 to 20% for leg press. After a 2 to 4-min rest, the weight
was again increased by 5 to 10% for bench press, and 10 to
20% for leg press, and the individual was instructed to
attempt a 1-RM. If the attempt was successful, the weight
was increased accordingly, and a further attempt was per-
formed after a 2 to 4-min rest. If the participant failed, a 2
to 4-min rest period was provided and the resistance was
reduced by 2.5 to 5% for bench press and 5 to 10% for leg
press. Testing was terminated when the participant could
not complete one repetition with proper technique. All
subjects were given verbal encouragement to facilitate max-
imal effort contractions. All tests were administered by the
same experienced investigator. To avoid learning effects, all
participants were accustomed to the testing procedures
under the supervision of a certified strength training
instructor during the familiarization period.
Aerobic capacity
V˙O2max was determined using a maximal graded exer-
cise test on a motorized treadmill using previously
described methods [25]. Briefly, subjects performed a
5-min warm-up at a 4% gradient and a self-selected
speed. Treadmill grade was then increased by 2% every
2 min until a grade of 10% was reached. If subjects were
able to continue exercising after completion of this
stage, speed was increased by 0.5 km·h− 1 (if the initial
selected speed was < 7.0 km·h− 1) or by 1.0 km·h− 1 (if the
initial speed was ≥ 7.0 km·h− 1). Oxygen uptake (V˙O2 )
and carbon dioxide output were determined using an
open-circuit breath-by-breath online data acquisition
system (Quark b2, Cosmed, Rome, Italy). Heart rate was
continuously monitored with a heart rate monitor (Polar
Vantage, Polar Electro, Kempele, Finland). Post-exercise
blood lactate concentration was determined 1min after
termination of exercise using a 5 μL capillary blood sam-
ple obtained from the tip of the middle finger (Lactate
Pro, Akray, Kyoto, Japan). The highest value of V˙O2 ob-
served over 30 s during the final stages of the test was re-
corded as V˙O2max . V˙O2max was assumed, if either a
leveling-off of V˙O2 was observed, or if at least two of the
following criteria were met: (1) respiratory exchange ra-
tio ≥ 1.15; (2) heart rate no less than 10 beats below age-
predicted maximal heart rate; (3) blood lactate concentra-
tion > 8.0 mmol·L− 1.
MRI
Fat free cross-sectional areas of the upper arms and upper
legs were assessed using a whole-body 1.5 T scanner
(MAGNETOM Symphony, Siemens Medical Solutions,
Erlangen, Germany). MRI was performed 2 days before
the familiarization period and 48 h after the 12-week train-
ing protocol (Fig. 1). Transaxial images were obtained by a
T1-weighted, spin-echo sequence with a 363ms repetition
time and a 17ms echo-time. The images consisted of a 50
cm field of view and a 512 × 352 pixel matrix. Subjects
were lying in a prone position with their arms stretched
overhead and their hands and feet fastened with Velcro
straps to prevent rotation. Arms and legs were also slightly
elevated using supporters to ensure that all limbs were
parallel to the table. After an initial phase of 15min lying
supine to control fluid shifts, the individual turned to the
prone position, and sagittal scout images were obtained to
determine the most distal part of the humeral and femoral
condyles, respectively. Subsequently, 10-mm transversal
images were taken 15 cm proximal to the most distal
border of the humeral condyles, and 25 cm proximal to
the most distal border of the femoral condyles, respect-
ively. Images were transferred to a workstation and
analyzed with the National Institutes of Health image
analysis software program (Image J1.35, Rasband, W.S.
1997–2006). Fat free cross-sectional areas (CSAFFM) of the
scans were determined using a semi-automated threshold-
ing technique as follows: at first, thresholds for fat free tis-
sue (including intramuscular vasculature and connective
tissue) and adipose tissue (including skin) were selected
on the basis of the gray-level histograms of each image.
Pixels were then color-coded according to the thresholds,
and a semi-transparent copy of fat free tissue was
superimposed on the original gray-level image to verify
the accuracy of the selected tissue area. Fat free cross-
sectional area in each image was then calculated as the
sum of the given pixel of the respective tissue area (includ-
ing bone and intramuscular fat) multiplied by the individ-
ual pixel surface area. All images were read and analyzed
by a single, trained investigator. Intra-observer differences
by experienced investigators are typically < 2% [26].
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Bioelectric impedance spectroscopy
Bioelectric impedance spectroscopy (BIS) was performed
with a SEAC SFB3 multifrequency phase-sensitive bio-
electrical impedance monitor (Impedimed, Eight Mile
Plains, Qld, Australia) via a tetrapolar electrode arrange-
ment following standard procedures that have been
previously described in detail [27]. Briefly, current intro-
ducing electrodes (2.0 cm × 2.0 cm, Impedimed Inc.,
Carlsbad, CA, USA) were placed on the dorsal surface of
the right hand and foot just below the metacarpal-
phalangeal and metatarsal-phalangeal joints, respectively.
Whole-body resistance was then determined by position-
ing two voltage-sensing electrodes (same type as current
introducing electrodes) on the dorsal surfaces of the
right wrist and ankle midline between the styloid
processes of the ulna and radius and midline between
the medial and lateral malleoli, respectively. Segmental
measurements were obtained by suggestions of Organ
et al. [28]. Additional electrodes were placed at the
contralateral hand and foot in correspondence to the
equivalent positions of the electrodes at the right side of
the body. By introducing the current via the right side of
the body, resistances of the right arm (i.e., right leg)
could be determined by measurements between the
voltage-sensing electrodes located at the right and left
wrist (i.e., right and left ankle). Resistances of the contra-
lateral side were determined in accordance by introdu-
cing the current via the left side of the body. After
calibrating the measurement unit according to the
guidelines of the manufacturer and lying 10 min supine
to allow body fluids to stabilize, a sinusoidal current of
190 μA was applied and impedance and phase angle
were recorded at 496 logarithmically spaced frequencies
between 5 kHz to 1000 kHz. Infinite resistance (R∞), and
extracellular resistance (RE = 0 kHz) were obtained by fit-
ting impedance data to the Cole-Cole-equation [29]
using the software provided by the manufacturer (v1.5.
2003, Impedimed, Mansfield, Queensland, Australia).
Subsequently, whole-body fluid volumes were derived on
the basis of the Hanai equation [30], and considering
differences in limb and trunk geometry. Specific details
of the methodology are provided by Stahn et al. [27, 31].
For the computation of total body water (TBW), the
second-generation mixture theory equation was employed
[32]. Specific resistivities for intracellular and extracellular
water were 273.9Ω∙cm and 40.5Ω∙cm, respectively [33,
34]. Bioimpedance measurements can be performed with
high within-day and between-day reliability, with an aver-
age coefficient of variation for within-day and between-
day variability of approximately 1 to 2% and 2 to 3%, re-
spectively, when experienced investigators employ strictly
standardized measurement protocols [31]. For the device
employed in the present study, RE and R∞ have been
reported to be within about 3% of theoretical values over a
range of resistances typically observed in adults [35]. Body
mass was measured barefoot, after voiding, in minimal
clothes and on a calibrated electronic digital scale to the
nearest 100 g. Standing height was measured barefoot to
the nearest 0.1 cm using a stadiometer. FFM was derived
from TBW assuming constant mean hydration of FFM of
73.2%. The ratio of extracellular to intracellular spaces
was used to assess changes in hydration status (e.g., ex-
pansion of extracellular fluid space). Similarly, estimates of
FFM were obtained for body segments. However, given
the uncertainty of how mixture effects are accounted for
with segmental measurements [33, 34], segmental TBW
was based on the computation of intracellular and extra-
cellular fluid volumes using the simple resistance-volume
relationship of a cylinder [31]. Segment lengths were mea-
sured between the respective voltage-sensing electrodes to
the nearest 0.1 cm using a flexible steel tape (Lufkin,
Cooper Tools, Apex, NC, USA). In line with whole-body
measurements, specific resistivities were 273.9Ω∙cm and
40.5Ω∙cm for intracellular and extracellular water,
respectively.
Statistical analysis
Descriptive data are reported as means and standard de-
viations unless stated otherwise. Differences between
groups at baseline were examined by independent t-
tests. Whole-body FM and FFM, strength and aerobic
capacity were examined using linear mixed models ad-
justed for body mass with Time (pre vs. post) and Treat-
ment (WP +HMB vs. WP + PLA) as fixed factors and
subject as a random factor. Identical models were ap-
plied for segmental (arm and leg) FFM, FM and CSAFFM,
but additionally including side (left vs. right) as a fixed
factor. Covariance matrices were determined by re-
stricted maximum likelihood (REML) estimation. P-
values were obtained by using Satterthwaite’s approxi-
mation for denominator degrees of freedom. Normality
and homogeneity were checked by Shapiro–Wilk tests
and visual inspections of plots of residuals against fitted
values. Within-subject differences for each group were
assessed using family-wise Bonferroni-corrected paired
t-tests (corrected for the number of all outcomes per
group). Effect sizes were expressed as standardized mean
differences (Cohen’s d) and 95% confidence intervals
using a bootstrapping procedure [36]. The Type I error
level was set to 0.05 (two-sided) for all testing. All statis-
tical analyses and graphical illustrations were carried out
using the software package R [37].
Results
Baseline subject characteristics are provided in Table 1.
There were no significant differences between groups for
age, height, body mass, and body composition. Results from
mixed-model ANOVAs are provided in the Additional file 3:
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Table S3. Body side did not show any significant inter-
action with Time or Time by Treatment and Side. To
achieve optimal parsimony, the models were reanalyzed for
all outcomes after excluding body side as an additional pre-
dictor. We did not observe any violations of model as-
sumptions, and normality of residuals was confirmed by
Shapiro-Wilks tests (all Ps > 0.307).
Whole-body FFM and FM
Hydration status as assessed by the ratio of extra- to
intracellular water remained unchanged between pre
and post (WP + HMB: P = 0.16; WP + PLA: P = 0.20).
Individual changes in whole-body FFM are provided in
Fig. 2a. In the WP + PLA group, two subjects showed a
strong increase (> 4 kg), two subjects a moderate (2 to
4 kg) and three subjects a small increase or no increase
(< 2 kg) in whole-body FFM. In contrast, in the WP +
HMB group, only one subject demonstrated a small in-
crease in whole-body FFM, and this change was actually
close to 2 kg (i.e., 1.88 kg). Four subjects responded
with a moderate, and three subjects with a strong
whole-body increase in the WP + HMB group. Whole-
body FFM significantly increased from baseline to week
12 in both groups (P < 0.001 for Time) (Fig. 2). The
average gains in whole-body FFM were more pro-
nounced in WP + HMB, which increased from 65.4 ±
7.1 to 68.8 ± 6.6 kg compared to a change from 64.7 ±
7.4 to 67.0 ± 7.7 kg in WP + PLA (note that Fig. 2 dis-
plays medians not means). Simple comparisons for each
group showed that this increase was significant for
WP + HMB (P = 0.005), but not for WP + PLA (P =
0.29). The interaction between Treatment and Time
was not significant (P = 0.26). Whole-body FM
remained unchanged in both groups, showing no main
or interaction effects (P = 0.59 and P = 0.56 for Time
and Time by Treatment, respectively).
Segmental FFM
Changes in arm and leg FFM are shown in Fig. 2b and c
(cases include left and right measurements). In WP +
PLA, arm FFM increased slightly (< 0.1 kg) in five cases,
moderately (0.1 to 0.2 kg) in one case, and strongly in
six cases (> 0.2 kg). In the WP +HMB group, all arm
FFM gains were moderate to strong (five cases showed
moderate increases, and 11 cases demonstrated strong
increases). In the WP + PLA group, leg FFM showed
small changes (< 0.5 kg) in six cases, moderate increases
(0.5 to 1 kg) in five cases, and strong gains (> 1 kg) in
one case. By comparison, in the WP +HMB group,
three cases showed small changes, six cases moderate
gains, and seven cases strong gains. Arm and leg FFM
showed a significant effect for Time (P < 0.001 for arm
and leg FFM, respectively). As shown in Fig. 2, all
Table 1 Participant characteristics at baseline
WP + PLA (n = 7) WP + HMB (n = 8) t P
Age, yrs 21.6 ± 1.0 22.6 ± 1.8 −1.4 0.19
Height, cm 180.6 ± 5.1 181.4 ± 5.2 −0.29 > 0.5
Body mass, kg 80.3 ± 10.3 79.4 ± 9.6 0.16 > 0.5
Fat mass, % 24.5 ± 2.6 24.1 ± 2.3 0.45 > 0.5
Values are means ± SD
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within-subject comparisons for each group were signifi-
cant. Changes from baseline to week 12 were similar for
arm FFM (WP + PLA + 6.1% vs. WP +HMB + 9.2%),
whereas leg FFM indicated larger increases in WP +
HMB (WP + PLA: 7.6 ± 1.2 vs. 8.0 ± 1.0 kg, + 7.0%; WP +
HMB: 7.7 ± 1.6 vs. 8.7 ± 1.3 kg, + 14.2%). This was con-
firmed by a significant interaction between Treatment
and Time for leg FFM (P = 0.007), and very large effect
size for the difference in change scores between groups
(Fig. 3).
MRI
Arm and leg CSAFFM were significantly increased in re-
sponse to the intervention (P < 0.001 for arm CSAFFM and
leg CSAFFM, respectively). The changes from baseline to
week 12 were similar between groups (Table 2), with no
significant interactions between Time and Treatment
(arm CSAFFM: P = 0.31; leg CSAFFM: P = 0.77).
Maximal strength
1-RM leg press and 1-RM bench press were significantly
increased after the training (P < 0.001) (Table 2) with no
changes between treatment groups (Time × Treatment:
P = 0.41 and P = 0.85 for 1-RM leg press and 1-RM
bench press, respectively).
Aerobic capacity
There were no changes in absolute V˙O2max (Time: P =
0.49 and Time × Treatment: P = 0.96). Relative V˙O2max
was slightly decreased at week 12 compared to baseline
(Table 2). The main effect for Time was close to statis-
tical significance for relative V˙O2max (P = 0.051), with no
differences for these changes between groups (P = 0.91
for Time × Treatment).
Discussion
We investigated the effects of whey protein supple-
mentation combined with HMB vs. whey protein
supplementation and placebo on body composition,
strength, and aerobic capacity in healthy, young men
after a periodized 12-week resistance training. We
found training-induced changes in whole-body and
segmental FFM, and maximal strength in both groups.
The intake of whey protein plus HMB resulted in
larger increases in segmental FFM compared to inges-
tion of whey protein only.
Our results provide new insights into the discrepancy
between previous studies showing that HMB supple-
mentation enhances resistance training-induced gains in
hypertrophy and those that could not confirm any
additional ergogenic benefits of HMB on body compos-
ition. We found increases in whole-body FFM of 2.2 kg
in WP + PLA and 3.4 kg in WP +HMB. These results
are in agreement with previous studies, reporting gains
of about 2 kg in whole-body FFM after twelve weeks of
resistance training in young men not receiving any HMB
supplementation [4, 6, 8]. In contrast, we could not
replicate the large gains in whole-body FFM reported for
the HMB supplemented groups in these studies.
Kraemer et al. [4], Wilson et al. [8], and Lowery et al. [6]
Fig. 3 Effect of HMB on body composition, strength, and cardiopulmonary fitness after a 12-week resistance training program. Effect sizes are
Cohen’s d for differences between change scores. P-values are based on t-statistics for unpaired comparisons. CI, confidence interval adjusted for
multiple comparisons, i.e., 99.5%). CSAFFM, FFM cross-sectional area. V˙O2max, maximal oxygen uptake
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observed gains of about 7 to 8 kg FFM in subjects supple-
mented with 3 g of HMB per day. Our results are more in
line with data recently published by Jakubowski et al. [20],
who reported 2.3 kg and 2.6 kg gains in whole-body FFM
after 12-weeks of resistance training with protein plus
HMB (3 g per day) and protein plus leucine (3 g per day)
supplementation, respectively. Such moderate increases in
FFM are also supported by a recent meta-analysis, show-
ing that with total protein intake of at least 1.6 g·kg− 1·day−
1 training-induced gains in FFM can reach a maximum of
about 4 kg with an average of about 1.5 kg [38].
Since the difference in gains between WP +HMB and
WP+ PLA was considerably smaller compared to previous
studies [4, 6, 8], we failed to detect a significant treatment
effect on whole-body FFM. To verify this, we performed a
power analysis using the R package simr. Monte Carlo
simulations were used to assess the power for the mixed
model investigating the effects of Time and Treatment.
One thousand simulations were run to assess power for
samples between n = 20 and 100. We found that a sample
size of n = 60 individuals per group would have been
needed to detect a significant treatment effect of WP+
HMB with > 80% power (α = 0.05, two-sided) if there is
one. It is also possible that whole-body BIS might not have
been accurate and precise enough to detect any differ-
ences in body composition between the groups. Whereas
other studies also failed to detect changes in body com-
position using dual-energy x-ray absorptiometry (DXA)
[20], future studies should consider more sophisticated
techniques such as DXA, air displacement plethysmogra-
phy, or magnetic resonance imaging to examine the effects
of HMB on whole-body composition.
Segmental FFM seemed to be more sensitive in detect-
ing the effect of HMB. We observed larger effect sizes for
gains in segmental FFM compared to gains in whole-body
FFM (d = 1.12 vs. 0.60 for leg FFM and whole-body FFM,
respectively). Increases in leg FFM were significantly larger
in WP +HMB (+ 14.2%) compared to WP+ PLA (+ 7.0%),
whereas no difference in gains was detected for whole-
body FFM. We also investigated changes in segmental
CSAFFM using MRI measurements. Neither arm nor
leg CSAFFM revealed any hypertrophic effect. We attribute
this to methodological differences between the approaches
for assessing segmental FFM. In line with previous studies,
CSAFFM was assessed from a single MRI scan of the arm
and leg, respectively. Training-induced changes in muscle
volume are not identical along with muscles, and a single
slice may not be representative of changes in total limb
composition [39]. This is in line with a recent validation
study comparing muscle thickness and volume deter-
mined by ultrasound and MRI [40]. The authors of the
study concluded that a muscle thickness measurement at
50% of vastus lateralis length is a reliable index of muscle
volume at a single time point, but poorly tracks changes
in muscle volume. There was also no significant correl-
ation between changes in muscle volume and changes in
muscle thickness, highlighting the impact of resistance
training on regional hypertrophy [40].
In the present study, we also used segmental BIS to
determine arm and leg FFM volume. We have previ-
ously shown that segmental BIS can provide accurate
estimates of arm and leg muscle volume compared to
limb volume measurements using MRI [41]. Because
segmental measurements for estimating FFM reflect
more closely the underlying biophysical model of BIS
to whole-body BIS (assumption of isotropic conductor
with homogeneous cross-sectional area and consistent
proportions specific tissues), we expected segmental
Table 2 Body composition, strength and maximal oxygen uptake pre- and posttraining
WP + PLA (n = 7) WP + HMB (n = 8)
Pre Post t P Cohen’s d Pre Post t P Cohen’s d
Body composition
Body mass, kg 80.3 ± 10.3 83.2 ± 11.4 − 2.9 0.33 − 1.10 (− 2.5, 0.3) 79.4 ± 9.6 82.8 ± 8.9 − 4.36 0.04 − 1.54 (− 3.1, − 0.03)
FM, kg 15.6 ± 7.0 16.2 ± 7.2 −0.84 > 0.5 − 0.32 (− 1.42, 0.81) 14.0 ± 5.4 14.0 ± 4.8 0.03 > 0.5 0.01 (− 1, 1.02)
FM, % 18.9 ± 7.4 18.9 ± 7.5 0.06 > 0.5 0.02 (− 1.06, 1.10) 17.4 ± 5.8 16.7 ± 5.0 0.87 > 0.5 0.31 (− 0.74, 1.34)
CSAFFM arm, cm
2* 55 ± 6 59 ± 8 − 4.86 < 0.01 −1.84 (− 3.72, − 0.06) 61 ± 13 67 ± 14 − 5.25 < 0.01 −1.86 (− 3.62, − 0.19)
CSAFFM leg, cm
2** 160 ± 16 166 ± 16 − 3.72 0.031 −1.41 (− 2.99, 0.14) 161 ± 24 168 ± 25 −5.53 < 0.01 −1.96 (− 3.78, − 0.23)
Maximal strength
Bench press, kg 54 ± 13 66 ± 16 − 9.4 < 0.001 − 3.55 (− 6.76, − 0.73) 57 ± 12 69 ± 13 − 13.98 < 0.001 − 4.94 (− 8.98, − 1.43)
Leg press, kg 177 ± 35 290 ± 60 −9.58 < 0.001 − 3.62 (− 6.89, − 0.76) 185 ± 52 286 ± 54 − 10.59 < 0.001 −3.74 (− 6.86, − 0.98)
Maximal oxygen uptake
ml·min− 1 4.4 ± 0.5 4.3 ± 0.3 0.74 > 0.5 0.28 (− 0.84, 1.38) 4.3 ± 0.5 4.2 ± 0.5 0.41 > 0.5 0.14 (− 0.88, 1.16)
ml·min− 1·kg− 1 55.0 ± 6.6 52.5 ± 7.2 1.9 > 0.5 0.72 (− 0.52, 1.93) 54.2 ± 4.1 51.5 ± 6.5 1.4 > 0.5 0.49 (− 0.6, 1.56)
*n = 28 for arm CSAFFM (WP + HMB: n = 14, WP + PLA: n = 14
**n = 26 for leg CSAFFM (WP + HMB: n = 12, WP + PLA: n = 14
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measurements to be more accurate and precise than
whole-body FFM estimations [27, 28, 31]. The methodo-
logical difference between single slice recordings and total
limb estimations in tracking changes in segmental hyper-
trophy may also explain the lack of detecting an ergogenic
effect associated with HMB supplementation in two very
recent studies, employing similar study designs [20, 22].
However, it should also be noted that the subjects in the
present study were untrained men, whereas the afore-
mentioned study were performed in resistance-trained
men. It is possible that the mTOR and ubiquitin-
proteasome proteolytic pathways are already maximized
in resistance-trained athletes due to high training loads
and the time course of long-term physiological adapta-
tions and explain why muscle protein synthesis may not
be augmented in this population. This may be particularly
true, when sufficient protein and energy intake is provided
[22, 23]. The additional effects of HMB on body compos-
ition over and above regular protein intake might there-
fore only be observed in untrained participants, the elderly
population, and bedridden people, but not in resistance-
trained athletes [22].
HMB did not affect any of the performance measures
that were assessed in the present study. Maximal oxygen
uptake remained unchanged. The changes in 1-RM were
in a typical range reported in previous 12-week resist-
ance training studies for bench press [3, 8, 20] and leg
press [3], but considerably lower than those reported by
Kraemer et al. [4] and Lowery et al. [6]. Some of these
studies reported no [20] or a slight effect [3] of HMB on
1-RM gains, whereas others found a strong effect [4, 6,
8]. Our findings were in line with a study by Gallagher
et al. [42] that examined the effects of HMB, adminis-
tered in doses of 0 g, 3 g or 6 g per day on FFM and
strength during eight weeks of resistance training in 37
untrained men [42]. HMB supplementation resulted in
greater increases in FFM compared to a placebo group,
but there were no differences in gains of 1-RM between
groups. This supports the finding of the present study
that longer training programs with combined HMB sup-
plementation could lead to an increase in FFM without
any significant changes in 1-RM. It is also possible that
the discrepancy between changes in FFM and 1-RM is
related to methodologies issues in measuring body com-
position, i.e., that the increases in FFM are due to an in-
crease of extracellular water and not contractile tissue.
Classical bioelectrical impedance analysis performed at
50 kHz is particularly prone to changes between extra-
and intracellular because at this frequency the extracel-
lular space dominates the resistance [27, 31]. In the
present study we employed bioimpedance spectroscopy
that allows to distinguish between intra- and extracellu-
lar water based on a biophysical model. Since we did not
observe any significant changes in ECW/ICW ratios
between pre- and post-testing, suggesting that the
changes in FFM are unlikely to be the result of an ex-
pansion of extracellular water.
Moreover, whereas Gallagher et al. [42] found no
changes in 1-RM, they reported group differences be-
tween HMB and placebo supplemented groups in peak
isometric and isokinetic torque, stressing the importance
of testing specificity for interpreting performance mea-
sures of strength. In the present study, care was taken to
minimize the effect of non-specific testing, i.e., 1-RM
was determined using exercises that were also specific-
ally part of the intervention program (barbell bench
press, dumbbell bench press, and leg press). It is possible
that testing exercises unrelated to the training program
would have revealed larger increases for WP +HMB
compared to WP + PLA because of the greater increases
observed in segmental FFM, and reducing the effects as-
sociated with neurological adaptations on maximal
strength for specific exercises.
RelativeV˙O2max decreased slightly as a result of higher
body mass, but absolute V˙O2max was unchanged. This is
in contrast to several studies that reported an increase in
V˙O2max after HMB supplementation [10–12, 43]. All of
these studies investigated athletes in sports where aerobic
capacity and endurance play a key role and/or participants
who were exposed to a specific endurance training pro-
gram during the HMB supplementation. In contrast, in
the present study, participants were asked to refrain from
any additional exercise other than the strength training
program. We suggest that the differences between previ-
ously reported effects of HMB on V˙O2max and our find-
ings could be explained by the lack of intense
cardiovascular training in the present study.
The majority of previous studies assessing the effects of
HMB on body composition comprised a time frame of
eight weeks or less, which may be inadequate to identify
the adaptations unique to HMB supplementation [44].
The present study comprised twelve weeks, and according
to the authors’ knowledge, this is the longest placebo-
controlled study combining HMB and whey protein
supplementation to assess strength training-induced
effects on body composition. Notably, Jakubowski et al.
[20] and Tritto et al. [23] also investigated the effects of
HMB supplementation during a 12-week resistance train-
ing program. However, the study by Jakubowski et al. [20]
was not placebo-controlled, and Tritto et al. [23] did not
assess the combined effects of HMB and protein supple-
mentation [20, 23]. Moreover, the training program in the
present study was carefully designed and periodized into
two mesocycles (weeks 1 to 6 and weeks 8 to 12), which
were separated by a 1-week taper phase.
Our findings on whole-body composition confirm re-
cent studies revealing no additional benefit of HMB
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supplementation over and above regular protein intake
on body composition and strength [20, 22, 23]. However,
HMB supplementation was associated with significantly
greater gains in leg FFM, suggesting that measurements
of segmental limb composition are more sensitive to de-
tect smaller changes in FFM. It is possible that a more
elaborate timing of the supplementation schedule might
have further increased these effects. Exercise stimulates
a delayed increase in ubiquitin conjugating activity,
which induces a late-phase rise in protein degradation
that is critical for muscle adaptation to exercise [45].
Hence, it is possible that the timing of HMB administra-
tion in the study was suboptimal. All subjects received
protein supplementation immediately before exercise
and about 1 h after completion of the exercise, but
ingested HMB capsules at rather fixed points in time (in
the mornings, at lunch and in the evenings) and not ne-
cessarily aligned with the training sessions. However,
Wilson et al. [46] showed that HMB consumed 1 hour
prior to exercise decreased muscle soreness and reduced
the accumulation of lactate dehydrogenase compared to
a placebo or when the supplement was administered
post-exercise [46]. In line with that, the position stand
on HMB as a supplement by the International Society of
Sports Nutrition (ISSN) conclude that HMB’s acute ef-
fects are likely to be maximized by administering an
HMB dose before exercise [1]. However, the authors also
recommend that the chronic anabolic effects are opti-
mized by consuming three daily servings of 1 g each.
A critical limitation of the present study is the lack of
a non-supplemented control group, which would have
provided a better understanding of the resistance-
training induced effects per se, irrespective of any pro-
tein and HMB supplementation. We also acknowledge
that dietary habits were not assessed in the present
study, which presents a limitation of the current results
because it is possible that the placebo group might have
ingested a sub-optimal amount of dietary protein to
maximize adaptations to the resistance training program.
Finally, it should be noted that the whey protein in-
cluded 7.3% of leucine. Under normal conditions, ap-
proximately 5% (2 to 10%) of leucine is converted to
HMB [47]. Based on 60 g and 30 g of protein supple-
mentation on training and non-training days, this corre-
sponds to an additional availability of 0.2 g and 0.1 g
(max. 0.4 g and 0.2 g), respectively. We do not expect
these doses critically confounded our results by minim-
izing the effects attributed to the WP +HMB relative to
WP + PLA.
Conclusions
In summary, we conclude that HMB combined with
whey protein supplementation can modestly augment
training-induced increases in FFM in healthy adults.
Notably, we studied untrained individuals and the results
cannot be extrapolated to trained athletes. The differen-
tiation of segmental and whole-body measurements
could provide increased sensitivity to fully understand
the effects of nutritional supplementation on body com-
position. Our findings are relevant to individuals starting
an exercise program and aiming to maximize training-
induced gains in muscle mass. This includes clinical
conditions associated with muscle wasting or situations
of skeletal muscle deconditioning such as aging,
immobilization, sedentary lifestyles, bed rest and space-
flight [48]. Further studies are needed to elucidate opti-
mal dosage, administration of HMB and its interactions
with different levels of protein intake (i.e., low, moderate,
and high protein intake) to identify the most beneficial
usage of HMB in these settings.
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